Note 11 - Loss Per Share (EPS)

6 Months Ended

Jun. 30, 2022

Notes to Financial Statements

Earnings Per Share [Text Block]

NOTE 11. LOSS PER SHARE (EPS)

We calculate basic EPS under the two-class method under which all earnings (distributed and undistributed) are allocated to each class of common stock and participating securities based on their respective rights to receive dividends. Our outstanding convertible preferred stock are considered participating securities as the holders may participate in undistributed earnings with holders of common shares and are not obligated to share in our net losses.

We calculate diluted EPS by dividing the net income attributable to RiceBran Technologies common shareholders by the weighted average number of common shares outstanding during the period increased by the number of additional common shares that would have been outstanding if the impact of assumed exercises and conversions is dilutive. We calculate the dilutive effects of outstanding options, warrants, and nonvested RSUs that vest solely on the basis of a service condition are calculated using the treasury stock method. We calculate the dilutive effects of the outstanding preferred stock using the if-converted method.

Reconciliations of the numerators and denominators in the EPS computations follow.

	Three Months Ended June 30,						Six Months Ended June 30,
	2022			2021			2022			2021
NUMERATOR (in thousands):
Numerator for basic and diluted EPS - net loss	$	(2,621	)	$	(1,923	)	$	(4,137	)	$	(1,332	)
DENOMINATOR:
Weighted average number of shares of shares of common stock outstanding		52,082,641			45,398,791			51,874,930			45,323,786
Weighted average number of shares of common stock underlying vested RSUs		778,997			465,594			821,787			425,999
Denominator for basic and diluted EPS - weighted average number of shares outstanding		52,861,638			45,864,385			52,696,717			45,749,785

No effects of potentially dilutive securities outstanding were included in the calculation of diluted EPS for the three and six months ended June 30, 2022 and 2021, because to do so would be antidilutive as a result of our net loss. Potentially dilutive securities outstanding during the three and six months ended June 30, 2022 and 2021, included our outstanding convertible preferred stock, options, warrants and nonvested RSUs.